Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.2650
+0.0950 (4.38%)
NASDAQ· Last Trade: Jul 23rd, 11:18 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors